aspirin and refludan

aspirin has been researched along with refludan in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Turpie, AG	1
Yusuf, S	1
Bachli, EB; Meili, EO; Peter, U; Schneider, E; Schuepbach, RA	1
Horvath, M; Jilma, B; Jilma-Stohlawetz, P; Reiter, R	1
Daemgen-von Brevern, G; Geisen, C; Klaeffling, C; Lindhoff-Last, E; Luxembourg, B; Mani, H; Strubel, G; Toennes, SW	1

Reviews

1 review(s) available for aspirin and refludan

Article	Year
Anticoagulants in acute coronary syndromes. The American journal of cardiology, 1999, Sep-02, Volume: 84, Issue:5A Topics: Acute Disease; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dalteparin; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Recombinant Proteins	1999

Trials

2 trial(s) available for aspirin and refludan

Article	Year
Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial. The American journal of cardiology, 1999, Sep-02, Volume: 84, Issue:5A Topics: Adult; Angina, Unstable; Anticoagulants; Aspirin; Death, Sudden, Cardiac; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Risk; Treatment Outcome	1999
Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide. Transfusion, 2005, Volume: 45, Issue:3 Topics: Adult; Anticoagulants; Aspirin; Blood Component Removal; Blood Platelets; Cross-Over Studies; Deamino Arginine Vasopressin; Drug Synergism; Eptifibatide; Hemostatics; Hirudins; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Recombinant Proteins	2005

Article

Year

Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.

The American journal of cardiology, 1999, Sep-02, Volume: 84, Issue:5A

Topics: Adult; Angina, Unstable; Anticoagulants; Aspirin; Death, Sudden, Cardiac; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Risk; Treatment Outcome

1999

Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide.

Transfusion, 2005, Volume: 45, Issue:3

Topics: Adult; Anticoagulants; Aspirin; Blood Component Removal; Blood Platelets; Cross-Over Studies; Deamino Arginine Vasopressin; Drug Synergism; Eptifibatide; Hemostatics; Hirudins; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Recombinant Proteins

2005

Other Studies

2 other study(ies) available for aspirin and refludan

Article	Year
Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thrombosis and haemostasis, 2004, Volume: 91, Issue:5 Topics: Afibrinogenemia; Aspirin; Blood Coagulation Tests; Drug Therapy, Combination; Heparin; Hirudins; Humans; Infant, Newborn; Male; Recombinant Proteins; Recurrence; Thrombosis	2004
Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Factitious Disorders; Female; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Hirudins; Humans; Iliac Artery; Middle Aged; Munchausen Syndrome; Phenprocoumon; Platelet Aggregation Inhibitors; Recombinant Proteins; Recurrence; Reoperation; Ticlopidine; Treatment Refusal; Vascular Surgical Procedures	2007

Article

Year

Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia.

Thrombosis and haemostasis, 2004, Volume: 91, Issue:5

Topics: Afibrinogenemia; Aspirin; Blood Coagulation Tests; Drug Therapy, Combination; Heparin; Hirudins; Humans; Infant, Newborn; Male; Recombinant Proteins; Recurrence; Thrombosis

2004

Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions.

Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Factitious Disorders; Female; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Hirudins; Humans; Iliac Artery; Middle Aged; Munchausen Syndrome; Phenprocoumon; Platelet Aggregation Inhibitors; Recombinant Proteins; Recurrence; Reoperation; Ticlopidine; Treatment Refusal; Vascular Surgical Procedures

2007